GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients.
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and ...
A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India.
The Manila Times on MSN
SLMC opens first inhaler clinic in PH
(UPDATE) ST. Luke’s Medical Center opened an inhaler clinic designed to assist patients with asthma and other pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback